European partnership fostering a European Research Area (ERA) for health research
The European partnership fostering a European Research Area (ERA) for health research, identified as HORIZON-HLTH-2022-DISEASE-03-01, is a key initiative under Horizon Europe aimed at strengthening and integrating health research across Europe and beyond. Its main purpose is to tackle diseases and reduce the disease burden through collaborative research, particularly focusing on large-scale Investigator-Initiated Clinical Studies (IICSs) and developing evidence-based health policies.
Who is Funded
This section outlines the general eligibility criteria for funding, detailing who can apply, where the projects should be implemented, and the overarching goals that the European Partnership for Health Research aims to achieve.
What is Funded
This section details the types of projects and thematic areas that are eligible for funding, specifies which costs are covered, and indicates the typical maturity or developmental stage of supported projects.
Type and Scope of Funding
This section provides information on the financial support available, including the types of funding instruments, the amounts allocated, and the expected duration for projects and the overall partnership.
Conditions and Requirements
This section outlines the essential rules and specific conditions that applicants and beneficiaries must adhere to, covering aspects like application terms, collaboration requirements, budget stipulations, and other key operational provisions.
Application Procedure
This section guides applicants through the procedural aspects of the program, from how to submit applications to the evaluation and selection process, ensuring clarity on the steps involved.
Legal Basis
This section identifies the fundamental legal and official documents that establish and govern the European partnership for health research, providing the framework for its operation and funding activities.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
10,000,000 EUR (per third party for cascade funding)
Allocated Budget:
For Phase 1 (2 years), the EU contribution is limited to a maximum of 30,000,000 EUR (max 30% of total eligible costs). The total EU contribution for the overall 7-year duration is expected to be 110,000,000 EUR (30,000,000 EUR for Phase 1 and 80,000,000 EUR for Phase 2), provided Member States commit matching funds.
Deadline:
21.04.2022
Award Channel:
Framework Programme Call
Region:
EU Member States, countries associated to Horizon Europe, United States of America, and other third countries globally.
Sectors:
Healthcare, Medical Technology, Research and Development, Pharmaceutical Industry, Food Processing, Agriculture and Agribusiness
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Market Introduction, Scaling, Commercialization, Feasibility Study, Implementation
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Additional Partners:
Collaborations with other Horizon Europe partnerships (institutionalized and co-funded) and missions are expected. Synergies with EU programmes including EU4Health, Digital Europe Programme (DIGITAL), European Social Fund Plus (ESF+), European Regional Development Fund (ERDF), InvestEU, Recovery and Resilience Facility (RRF), and Technical Support Instrument (TSI) are encouraged. Cooperation with international organisations and non-European institutions and experts may also be considered.
Website: